Deepak Nitrite Limited Invests ₹135 Crores in Subsidiary Through OCRPS Issuance
Deepak Nitrite Limited has invested ₹135 crores in its subsidiary Deepak Chem Tech Limited through OCRPS issuance, with ₹110 crores from Deepak Phenolics Limited and ₹25 crores directly. DCTL operates chemical plants in Gujarat with FY 2024-25 turnover of ₹9.43 crores. The investment aims to strengthen capital base and support project expenses while maintaining 100% group control.

*this image is generated using AI for illustrative purposes only.
Deepak Nitrite Limited has announced a substantial investment of ₹135 crores in its wholly owned subsidiary Deepak Chem Tech Limited (DCTL) through the issuance of 9% Optionally Convertible Redeemable Preference Shares (OCRPS). The transaction was completed on March 26, 2026, and disclosed under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Investment Structure and Details
The capital infusion involves two separate allotments of OCRPS by DCTL. The investment structure demonstrates a coordinated approach between Deepak Nitrite Limited and its subsidiary entities to strengthen DCTL's financial position.
| Investment Details: | Amount |
|---|---|
| Total Investment: | ₹135 crores |
| Investment by Deepak Phenolics Limited: | ₹110 crores |
| Direct Investment by Deepak Nitrite Limited: | ₹25 crores |
| OCRPS Face Value: | ₹100 each |
| Interest Rate: | 9% |
OCRPS Allocation Breakdown
DCTL issued a total of 1,35,00,000 OCRPS with specific allocations to each investing entity. Deepak Phenolics Limited, another wholly owned subsidiary of Deepak Nitrite Limited, received 1,10,00,000 OCRPS aggregating to ₹110 crores. Simultaneously, Deepak Nitrite Limited directly acquired 25,00,000 OCRPS worth ₹25 crores.
About Deepak Chem Tech Limited
DCTL, incorporated on October 9, 2020, operates specialized chemical manufacturing facilities across Gujarat. The company's current operations include plants for Fluorination, Nitric Acid, Nitration and Hydrogenation processes. Prior to this investment, DCTL maintained a paid-up capital of ₹2099.50 crores, comprising ₹499.50 crores in equity shares and ₹1600 crores in preference shares.
| DCTL Financial Performance: | Amount |
|---|---|
| FY 2024-25 Turnover: | ₹9.43 crores |
| FY 2023-24 Turnover: | ₹0.86 crores |
| Current Paid-up Capital: | ₹2099.50 crores |
| Equity Share Capital: | ₹499.50 crores |
| Preference Share Capital: | ₹1600 crores |
Transaction Compliance and Structure
The investment qualifies as a Related Party Transaction since both DCTL and Deepak Phenolics Limited are wholly owned subsidiaries of Deepak Nitrite Limited. However, the company confirmed that both transactions were conducted on an arms-length basis with OCRPS issued at par value of ₹100 each. The investment required no governmental or regulatory approvals and was completed through cash consideration via normal banking channels.
Strategic Objectives
The primary objective of this capital infusion is to strengthen DCTL's capital base and provide financial support for project expenses and general corporate purposes. The business activities of DCTL align with the main line of business of the listed entity, ensuring strategic coherence within the group structure. Following this investment, Deepak Nitrite Limited continues to maintain 100% control of DCTL's equity share capital, while collectively holding 100% of the preference share capital along with Deepak Phenolics Limited.
Historical Stock Returns for Deepak Nitrite
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.89% | +0.60% | -12.84% | -25.19% | -30.50% | -16.34% |
What specific expansion projects or capacity additions is DCTL planning with this ₹135 crore capital infusion?
How will this investment impact Deepak Nitrite's consolidated debt-to-equity ratio and overall financial leverage?
Could this significant investment in DCTL signal Deepak Nitrite's strategy to compete more aggressively in the specialty chemicals market?


































